The Vitals | Healthspan Explained: A Miniseries | Episode 1:The Future of Aging

Mount Sinai Health System
Mount Sinai Health SystemJun 3, 2026

Why It Matters

Bridging the gap between longer lives and healthier lives could reduce chronic disease costs and empower patients to age with functional independence.

Key Takeaways

  • Healthy aging prioritizes functional independence, cognition, and mobility.
  • Lifespan gains outpace healthspan, creating years of chronic disease burden.
  • Mount Sinai integrates biomarkers, imaging, and AI to map aging trajectories.
  • Evidence‑based supplements (e.g., vitamin D, omega‑3) differ from hype‑driven products.
  • Clinical trials aim to translate longevity science into actionable screening protocols.

Summary

The inaugural episode of The Vitals miniseries introduces Mount Sinai’s evidence‑driven approach to healthy aging. Host Shruti Naik and panelists—immunologist Dr. Miriam Merad, imaging expert Zahi Fayad, and longevity physician Fiorina Kyritsi—clarify the distinction between lifespan (years lived) and healthspan (years lived well), emphasizing that recent medical advances have extended life without proportionally improving quality of life.

Key insights include the recognition that the health‑span gap fuels prolonged periods of chronic disease, straining patients and health systems. The discussion highlights the need for quantifiable biomarkers and multimodal imaging to track molecular and physiological changes, enabling researchers to correlate these metrics with functional outcomes. AI‑driven analyses compare young versus old immune profiles across species, generating hypotheses for targeted interventions.

Panelists cite concrete examples: cardiovascular imaging to detect pre‑symptomatic plaque, and rigorous evaluation of supplements such as vitamin D and omega‑3, which possess solid trial data but lack longitudinal lifespan studies. They caution against “bro‑science” hype on social media, urging clinicians to assess risk, efficacy, and measurable outcomes before recommending costly regimens.

The implications are clear: by establishing a gold standard for aging biomarkers and integrating them into clinical practice, Mount Sinai aims to narrow the lifespan‑healthspan gap, offering patients evidence‑based strategies to maintain independence and vitality into later years.

Original Description

What if the goal isn't simply to live longer—but to live better, for longer?
In this special kickoff episode of The Vitals Healthspan Miniseries, guest host Shruti Naik sits down with Mount Sinai experts Fiorina Kyritsi, MD, Miriam Merad, MD, PhD, and Zahi Fayad, PhD, to explore the science of aging—and why the future of medicine may be less about extending lifespan and more about expanding healthspan.
The panel breaks down:
What aging actually is,
Why scientists still don't fully understand "healthy aging."
How emerging research is helping identify the biomarkers that may one day predict—and potentially improve—our aging trajectories.
The panel also separates evidence from hype, tackling supplements, social media longevity trends, personalized medicine, and the promise of large-scale research initiatives like the XPRIZE Healthspan competition.
Subscribe and follow The Vitals as we continue this six-part exploration of the science that could reshape how we age.
#TheVitals #HealthSpan #Longevity #HealthyAging #AgingResearch #MountSinai #PrecisionMedicine #PreventiveMedicine

Comments

Want to join the conversation?

Loading comments...